lobbying_activities: 1762915

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1762915	6092fdd4-b458-48ad-ba3c-c3e8e1ee7896	Q4	WAKE FOREST UNIVERSITY HEALTH SCIENCES	6781	WAKE FOREST UNIVERSITY HEALTH SCIENCES	2015	fourth_quarter	MMM	340(B) Drug Pricing Program Mega Guidance and comment letter to HRSA; Medicaid reform proposals and information regarding 1115 waiver requirements and state provider assessment cuts; Stage 3 Meaningful Use of Electronic Health Records and medical student restrictions; site-neutral payments language contained in the Bipartisan Budget Act and health care funding issues contained in the Consolidated Appropriations Act; residency slot increases; The Medicare Audit Improvement Act of 2015, (HR2156); Establishing Beneficiary Equity in the Hospital Readmission Program Act, (S688/HR1343; Resident Physician Shortage Reduction Act of 2015, (HR2124/S1148).	Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE		130000	0	0	2016-01-06T14:13:14.933000-05:00